Activation of peripheral blood T cells via the p75 interleukin 2 receptor

By using mAb and flow cytometry, a constitutive expression of the p75 IL-2R was revealed in human peripheral blood CD8+ T cells and TCR delta- 1+ T cells as well as in CD16+ NK cells. Anti-p75 IL-2R mAb almost completely inhibited the induction of cytolytic activity in these T cells by brief exposure to IL-2, as estimated by anti-TCR/CD3 mAb- targeted cytotoxicity. While anti-p55 IL-2R mAb alone inhibited the response only modestly, maximal inhibition was achieved by combining both anti-p55 and anti-p75 IL-2R mAbs. These results indicate that the p75 IL-2R constitutively expressed on peripheral blood CD8+ T cells and TCR delta-1+ T cells is predominantly responsible for the direct activation of these cells by IL-2.

[1]  K. Sugamura,et al.  Differential expression of the IL-2 receptor subunits, p55 and p75 on various populations of primary peripheral blood mononuclear cells. , 1989, Journal of immunology.

[2]  K. Sugamura,et al.  Activation of natural killer cells via the p75 interleukin 2 receptor , 1989, The Journal of experimental medicine.

[3]  T. Taniguchi,et al.  Interleukin-2 receptor beta chain gene: generation of three receptor forms by cloned human alpha and beta chain cDNA's. , 1989, Science.

[4]  H. Asao,et al.  Monoclonal antibody defining a molecule possibly identical to the p75 subunit of interleukin 2 receptor , 1989, The Journal of experimental medicine.

[5]  D. Olive,et al.  IL-2 receptors on circulating natural killer cells and T lymphocytes. Similarity in number and affinity but difference in transmission of the proliferation signal. , 1989, Journal of immunology.

[6]  K. Okumura,et al.  CD2 expression in murine B cell lineage. , 1989, International immunology.

[7]  J. Mclean,et al.  Immunochemical proof that a novel rearranging gene encodes the T cell receptor delta subunit. , 1987, Science.

[8]  W. Leonard,et al.  The IL-2 receptor beta chain (p70): role in mediating signals for LAK, NK, and proliferative activities. , 1987, Science.

[9]  W. Greene,et al.  Direct activation of human resting T cells by IL 2: the role of an IL 2 receptor distinct from the Tac protein. , 1987, Journal of immunology.

[10]  G. Stoter,et al.  Regulation of cytolytic activity in CD3- and CD3+ killer cell clones by monoclonal antibodies (anti-CD16, anti-CD2, anti-CD3) depends on subclass specificity of target cell IgG-FcR. , 1987, Journal of immunology.

[11]  L. Lanier,et al.  Dissection of the lymphokine-activated killer phenomenon. Relative contribution of peripheral blood natural killer cells and T lymphocytes to cytolysis , 1986, The Journal of experimental medicine.

[12]  D. Segal,et al.  Specific targeting of human peripheral blood T cells by heteroaggregates containing anti-T3 crosslinked to anti-target cell antibodies , 1986, The Journal of experimental medicine.

[13]  K. Sugamura,et al.  Distinct Reactivities of Four Monoclonal Antibodies with Human Interleukin 2 Receptor , 1985, Microbiology and immunology.

[14]  J. Bluestone,et al.  Specific targeting of cytotoxic T cells by anti-T3 linked to anti-target cell antibody , 1985, Nature.

[15]  P F Davison,et al.  Preparation of bispecific antibodies by chemical recombination of monoclonal immunoglobulin G1 fragments. , 1985, Science.

[16]  J. Ortaldo,et al.  Characteristics of human large granular lymphocytes and relationship to natural killer and K cells , 1981, The Journal of experimental medicine.

[17]  B. Benacerraf,et al.  Hapten-specific T cell responses to 4-hydroxy-3-nitrophenyl acetyl. , 1980, Journal of immunology.